Wedge Capital Management’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-46,700
Closed -$936K 597
2017
Q1
$936K Buy
46,700
+2,481
+6% +$57.8K 0.01% 341
2016
Q4
$1.11M Sell
44,219
-596
-1% -$14.1K 0.01% 322
2016
Q3
$1.05M Sell
44,815
-985
-2% -$23.1K 0.01% 318
2016
Q2
$916K Buy
45,800
+10,500
+30% +$196K 0.01% 323
2016
Q1
$598K Sell
35,300
-2,000
-5% -$41K 0.01% 393
2015
Q4
$828K Buy
+37,300
New +$776K 0.01% 357
2015
Q1
Sell
-65,400
Closed -$691K 619
2014
Q4
$691K Buy
65,400
+24,100
+58% +$285K 0.01% 388
2014
Q3
$516K Buy
+41,300
New +$576K 0.01% 446

Other funds holding OME

Wedge Capital Management's OME Position: Q2 2017 in Review

Wedge Capital Management sold out of Omega Protein (OME) in Q2 2017, closing a stake of 46,700 shares — an estimated $936K sold.

Wedge Capital Management first reported a position in OME in Q3 2014 and held it in 8 quarters. The position peaked at $1.11M in Q4 2016. 140 funds tracked by Wall St. Rank hold OME as of Q2 2017.

  • Wedge Capital Management reported no remaining Omega Protein position as of Q2 2017 after selling out during the quarter.
  • Wedge Capital Management sold 46,700 Omega Protein shares in Q2 2017, an estimated $936K.
  • Wedge Capital Management first reported a position in Omega Protein in Q3 2014 and held it in 8 quarters.
  • Wedge Capital Management's Omega Protein position peaked at $1.11M in Q4 2016.
  • 140 funds tracked by Wall St. Rank held Omega Protein as of Q2 2017.

Based on Wedge Capital Management's 13F filing for Q2 2017, filed 2 Aug 2017.